Columbia, MO, United States of America

Fabio Gallazzi

This inventor holds 1 USPTO granted patent. Top assignee: University of Missouri. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Fabio Gallazzi

Introduction

Fabio Gallazzi is an accomplished inventor based in Columbia, MO (US). He has made significant contributions to the field of biomedical research, particularly in the area of HIV treatment. His innovative work has led to the development of a patent that addresses critical health challenges.

Latest Patents

Fabio Gallazzi holds a patent titled "Peptide Inhibitors for the Inhibition of HIV Capsid." This patent represents a crucial advancement in the fight against HIV, showcasing his dedication to improving health outcomes through scientific innovation. He has 1 patent to his name, reflecting his commitment to research and development.

Career Highlights

Gallazzi is affiliated with the University of Missouri, where he continues to engage in groundbreaking research. His work at the university allows him to collaborate with other experts in the field and contribute to the academic community. His career is marked by a focus on developing solutions that can have a real-world impact on public health.

Collaborations

Throughout his career, Fabio has worked alongside notable colleagues, including Ujjwal Neogi and Anders Sonnerborg. These collaborations have enriched his research and expanded the scope of his innovations.

Conclusion

Fabio Gallazzi's contributions to the field of HIV research through his patent and collaborations highlight his role as a significant inventor. His work at the University of Missouri continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…